Reply
To the Editor-We appreciate the thoughtful letter of Cainelli et al. [1] questioning the validity of our findings suggesting a significant role for hepatitis A virus (HAV) infection in atherogenesis [2, 3] . Their skepticism is based on seroepidemiological data showing that regions with a high prevalence of HAV infection, such as Saudi Arabia, Yemen, Egypt, and sub-Saharan Africa, have a low prevalence of coronary artery disease (CAD), whereas regions with a lower prevalence of HAV infection, such as northern European countries and Australia, have a higher prevalence of CAD. We should note that the same disparities between prevalence of infectious disease and prevalence of atherosclerosis are often used more generically to rebut the role of any infectious agent in atherogenesis.
Cainelli et al. [1] , however, fail to consider that atherosclerosis is a multifactorial disease with no single contributing factor sufficient to cause disease by itself (with uncommon exceptions, such as familial hypercholesterolemia). Thus, although HAV infection is highly prevalent in the countries noted by Cainelli et al., other risk factors for atherosclerosis are lacking. If we assume for the moment that infection does contribute to atherosclerosis, infection by itself would not be sufficient to cause atherosclerosis; hence, in the absence of other contributing risk factors, CAD prevalence would be expected to be low in these countries, despite a high prevalence of HAV or other infections.
By parallel reasoning, a lower prevalence of HAV infection in northern European countries and in Australia can be associated
